8-K/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K/A

Amendment No. 1
to
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 18, 2010

BRADY CORPORATION
(Exact name of registrant as specified in its charter)

Wisconsin	1-14959	39-0971239
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6555 West Good Hope Road Milwaukee, Wisconsin	53223
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (414) 358-6600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Explanatory Note:

This Report on Form 8-K/A amends the Current Report on Form 8-K filed by the registrant on June 23, 2010 to correct information contained in Item 5.02, which is restated in its entirety.

Item 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

(d) On June 18, 2010, Brady Corporation (the “Corporation”) announced that Gary S. Balkema will join the Corporation’s Board of Directors, effective July 19, 2010. There was no arrangement or understanding pursuant to which Mr. Balkema was appointed director, and no related party transactions exist between the Corporation and Mr. Balkema.

Mr. Balkema has not been appointed to any committees of the Board of Directors at this time. Upon becoming a director, he will be eligible to participate in the Corporation’s equity incentive and other benefit plans on a basis similar to other non-employee directors and, as such, will receive a stock option award of 10,000 shares 14 days after he becomes a director.

A copy of the press release related to the appointment of Mr. Balkema to the Board of Directors is being provided to the Securities and Exchange Commission as Exhibit 99.1 attached herewith and is incorporated herein by reference.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

The following is filed as an Exhibit to this Report.

Exhibit No.	Description of Exhibit
99.1	Press Release of Brady Corporation, dated June 18, 2010, relating to the appointment of Gary S. Balkema.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRADY CORPORATION

Date: June 24, 2010

/s/ Thomas J. Felmer
Thomas J. Felmer
Senior Vice President &
Chief Financial Officer

EXHIBIT INDEX

EXHIBIT NUMBER	DESCRIPTION
99.1	Press Release of Brady Corporation, dated June 18, 2010, relating to the appointment of Gary S. Balkema.

EX-99.1

EXHIBIT 99.1

For More Information Contact:
Carole Herbstreit (414) 438-6882

Gary S. Balkema to join Brady Corporation Board of Directors.

MILWAUKEE (June 18, 2010)—Gary S. Balkema will join the Board of Directors of Brady Corporation (NYSE:BRC), effective July 19, 2010. Balkema, 54, is president of the Worldwide Consumer Care Division for Bayer AG and a member of the Bayer HealthCare Executive Committee.

Balkema joined Bayer in 1994 as president of Consumer Care USA. In 2000, he was appointed general manager of the Consumer Care Business Group, which ranks among the top consumer healthcare companies in the world, operating in more than 140 countries. His responsibilities included strategic direction and leadership for the business group worldwide. Prior to Bayer, Balkema was vice president and general manager of the Shulton Division and head of the Lederle Consumer Health Division, both at American Cyanamid, with leadership responsibility for manufacturing, sales, product management and strategic business management. He holds degrees in business administration and aeronautical science from Nathaniel Hawthorne College and received his MBA from Fairleigh Dickinson University.

“Gary will be a great addition to Brady’s board,” said Conrad Goodkind, lead independent director and chair of Brady’s corporate governance Committee. “Over the last 15 years, sales of Bayer’s Consumer Care group have quintupled to more than $3.8 billion through several large acquisitions and substantial organic growth. Gary’s breadth of business experience, including large-scale integration of new businesses and strategic marketing, will be a real asset as Brady continues to grow,” Goodkind said.

“While Brady’s past track record and vision for future growth coupled with a sound balance sheet is attractive in its own right, after gaining a deeper understanding of Brady’s breadth of product line, customer segments, and value proposition delivered through its diverse businesses, I am energized and eager to begin working with the Brady leadership team and other directors on the board to take Brady to the next level,” said Balkema.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is a leading diversified healthcare company based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Bayer Schering Pharma, Consumer Care and Medical Care divisions. Bayer HealthCare’s aim is to discover, manufacture and market products that will improve human and animal health worldwide.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect premises, products and people. Its products help customers increase safety, security, productivity and performance and include high-performance labels and signs, safety devices, printing systems and software, and precision die-cut materials. Founded in 1914, the company has more than 500,000 customers in electronics, telecommunications, manufacturing, electrical, construction, education, medical and a variety of other industries. Brady is headquartered in Milwaukee and employs about 7,000 people at operations in the Americas, Europe and Asia/Pacific. Brady’s fiscal 2009 sales were approximately $1.2 billion.

More information is available on the Internet at www.bradycorp.com.

##